Sugi Predict

Sugi Predict / Compounds / Betamethasone

Betamethasone

Betamethasone

SCHEMBL3224067

C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO.C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NR3C1

The experimentally established mechanism targets of Betamethasone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 known ✓ P04150 9/20 0.68
▸ CYP3A4 P08684 7/20 0.68
▸ HSD17B10 Q99714 7/20 0.68
▸ HIF1A Q16665 7/20 0.68
▸ TSHR P16473 3/20 0.68
▸ NFKB1 P19838 3/20 0.68
▸ PGR P06401 3/20 0.68
▸ PMP22 Q01453 3/20 0.68
▸ AR P10275 2/20 0.68
▸ CYP2D6 P10635 2/20 0.68
▸ MEN1 O00255 1/20 0.68
▸ KMT2A Q03164 1/20 0.68
▸ APEX1 P27695 1/20 0.68
▸ NPSR1 Q6W5P4 1/20 0.68
▸ IKBKB O14920 1/20 0.68
▸ CHUK O15111 1/20 0.68
▸ ADRB2 P07550 1/20 0.68
▸ NR3C2 P08235 1/20 0.68
▸ PLA2G2A P14555 1/20 0.68
▸ NFKB2 Q00653 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dexamethasone SCHEMBL3135309 1.00 NR3C1 (0.68) NR3C1CYP3A4HSD17B10HIF1ATSHR
Cortisone SCHEMBL14862166 0.92 HSD17B10 (0.69) NR3C1CYP3A4HSD17B10HIF1ATSHR
Dexamethasone SCHEMBL1408949 0.91 NR3C1 (0.72) NR3C1CYP3A4HSD17B10HIF1ATSHR
Betamethasone SCHEMBL13724083 0.91 NR3C1 (0.72) NR3C1CYP3A4HSD17B10HIF1ATSHR
Dexamethasone SCHEMBL322760 0.89 HIF1A (0.69) NR3C1CYP3A4HSD17B10HIF1ATSHR
Dexamethasone SCHEMBL4743981 0.86 HSD17B10 (0.65) NR3C1CYP3A4HSD17B10HIF1ATSHR
Betamethasone SCHEMBL28086533 0.86 HIF1A (0.66) NR3C1CYP3A4HSD17B10HIF1ATSHR
Triamcinolone SCHEMBL3043158 0.86 HSD17B10 (0.71) NR3C1CYP3A4HSD17B10HIF1ATSHR
Betamethasone SCHEMBL21808820 0.85 NR3C1 (0.76) NR3C1CYP3A4HSD17B10HIF1ATSHR
Dexamethasone SCHEMBL4085868 0.85 NR3C1 (0.76) NR3C1CYP3A4HSD17B10HIF1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010003430-A1 FORMULATIONS WITH POLYCARBOHYDRATESILOXANE COATINGS, THEIR PRODUCTION AND USE PETHYLATION GMBH (DE) 2010-01-14 — — WO disclosed
WO-2010003645-A1 FORMULATIONS WITH POLYCARBOHYDRATESILOXANE COATINGS, THEIR PRODUCTION AND USE PETHYLATION GMBH (DE) 2010-01-14 — — WO disclosed
EP-1689365-A1 DRUG DELIVERY VEHICLES AND USES THEREOF Pharmexa A/S (DK) 2006-08-16 — — EP disclosed
EP-1689778-A1 RGD TARGETING MOIETY ITS PORDUCTION AND USE Pharmexa A/S (DK) 2006-08-16 — — EP disclosed
EP-1557429-A1 Site-directed coupling of proteins Vectron Therapeutics AG (DE) 2005-07-27 — — EP disclosed
WO-2005053642-A1 DRUG DELIVERY VEHICLES AND USES THEREOF PHARMEXA A/S (DK) 2005-06-16 — — WO disclosed
WO-2005054293-A1 RGD TARGETING MOIETY ITS PORDUCTION AND USE PHARMEXA A/S (DK) 2005-06-16 — — WO disclosed
EP-1537858-A1 Drug delivery vehicles and uses thereof Vectron Therapeutics AG (DE) 2005-06-08 — — EP disclosed
EP-1538164-A1 RGD targeting moiety its production and use Vectron Therapeutics AG (DE) 2005-06-08 — — EP disclosed
US-20030064948-A1 Invasomes for therapy of disorders, their preparation and use VECTRON THERAPEUTICS AG (DE) 2003-04-03 — — US disclosed
EP-0977725-A1 NEW FATTY ACID DERIVATIVES NORSK HYDRO ASA (NO) 2000-02-09 — — EP disclosed
WO-1998032718-A1 NEW FATTY ACID DERIVATIVES NORSK HYDRO ASA (NO) 1998-07-30 — — WO disclosed
Send feedback